Bracebridge Capital LLC’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bracebridge Capital LLC’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-296,572	Closed	-$2.98M	–	110
2021 Q4	$2.98M	Hold	296,572	–	–	0.18%	45
2021 Q3	$3.01M	Hold	296,572	–	–	0.27%	38
2021 Q2	$2.97M	Buy	+296,572	New	+$3M	0.26%	36

Other funds holding MTACU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bracebridge Capital LLC's MTACU Position: Q1 2022 in Review

Bracebridge Capital LLC sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2022, closing a stake of 296,572 shares — an estimated $2.98M sold.

Bracebridge Capital LLC first reported a position in MTACU in Q2 2021 and held it in 3 quarters. The position peaked at $3.01M in Q3 2021. 5 funds tracked by Wall St. Rank hold MTACU as of Q1 2022.

Bracebridge Capital LLC reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
Bracebridge Capital LLC sold 296,572 MedTech Acquisition Corporation Unit shares in Q1 2022, an estimated $2.98M.
Bracebridge Capital LLC first reported a position in MedTech Acquisition Corporation Unit in Q2 2021 and held it in 3 quarters.
Bracebridge Capital LLC's MedTech Acquisition Corporation Unit position peaked at $3.01M in Q3 2021.
5 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2022.

Based on Bracebridge Capital LLC's 13F filing for Q1 2022, filed 11 May 2022.